IA
PLRX icon

IFP Advisors’s Pliant Therapeutics PLRX Stock Holding History

IFP Advisors’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Hold
0
– – – 4203
2024
Q4 		– Hold
0
– – – 3888
2023
Q1 		– Sell
-3
Closed -$1K – 4167
2022
Q4 		$1K Hold
3
– – ﹤0.01% 4442
2022
Q3 		$1K Buy
+3
New +$57 ﹤0.01% 4642

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

IFP Advisors's PLRX Position: Q1 2025 in Review

IFP Advisors held its Pliant Therapeutics (PLRX) position steady in Q1 2025 at 0 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #4203.

IFP Advisors first reported a position in PLRX in Q3 2022 and has held it in 2 quarters since. The position peaked at $1K in Q4 2022. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

  • IFP Advisors held 0 shares of Pliant Therapeutics worth $15 as of Q1 2025.
  • IFP Advisors left its Pliant Therapeutics share count unchanged in Q1 2025.
  • Pliant Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q1 2025, its #4203 holding.
  • IFP Advisors first reported a position in Pliant Therapeutics in Q3 2022 and has held it in 2 quarters since.
  • IFP Advisors's Pliant Therapeutics position peaked at $1K in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.